Skip to main content

Peer Review reports

From: Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial

Original Submission
4 May 2016 Submitted Original manuscript
Author responded Author comments
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
18 Aug 2016 Editorially accepted
27 Aug 2016 Article published 10.1186/s12879-016-1790-x

You can find further information about peer review here.

Back to article page